Vascular surgery, a multifaceted discipline encompassing a spectrum of interventions targeting blood vessel diseases, is indispensable in preserving vascular health and averting complications. From critical arterial procedures saving lives to cosmetic enhancements for varicose veins, vascular surgery addresses a diverse array of conditions affecting arteries, veins, and lymphatic vessels. Peripheral artery disease (PAD), atherosclerosis, aneurysms, venous insufficiency, and varicose veins are among the maladies confronted by vascular surgeons, each presenting unique challenges and symptoms. Employing a repertoire of surgical techniques ranging from conventional open surgeries to minimally invasive procedures, vascular surgeons undertake interventions such as angioplasty, stenting, endarterectomy, and bypass grafting to restore blood flow, alleviate symptoms, and forestall complications. Collaboration with allied medical specialties—interventional radiology, cardiology, neurology—is paramount for comprehensive patient care, ensuring tailored interventions addressing individual needs. Beyond acute emergencies, vascular surgeons advocate for preventive measures and long-term vascular health, emphasizing patient education, lifestyle modifications, and medical therapies to mitigate risk factors and enhance overall vascular well-being. Continuing innovations in imaging modalities and minimally invasive techniques underscore the field's commitment to optimizing patient outcomes and advancing vascular healthcare, epitomizing excellence in patient-centered care and the pursuit of vascular health.
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States